Multiple symmetric lipomatosis: A cross-sectional study to investigate clinical features and patients‘ quality of life

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021222

Enrollment

Registered

2020-04-02

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple symmetric lipomatosis

Interventions

Group 1: Patients with MSL are included. Questionnaires are used to collect: general data, anamnestic factors, comorbidities, symptoms, onset and course of the disease, course of therapy, EQ-5D-3L, PB

Eligibility

Sex/Gender

All

Age

0 Years to 100 Years

Inclusion criteria

Inclusion criteria: conformed diagnosis of MSL

Exclusion criteria

Exclusion criteria: other diagnosis or patient wish

Design outcomes

Primary

Measure	Time frame
Using the questionnaire, collected data on the development and development of MSL, as well as its symptoms, the patient's level of suffering is measured after the completion of the study and evidence of a possible pathogenesis is sought.	—

Secondary

Measure	Time frame
better understanding of the clinical picture	—

Countries

Germany

Contacts

Public ContactElisabeth Ipfelkofer

Universitätsklinikum Regensburg

elisabeth.ipfelkofer@ukr.de00499419446367

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026